[1] Dorobantu M,Fruntelata AG,Scafa-Udriste A,et al.B-Type Natriuretic Peptide(BNP) and Left Ventricular(LV) Function in Patients with ST-Segment Elevation Myocardial Infarction(STEMI)[J].Maedica(Buchar),2010,5(4):243-249.
[2] 刘小燕,董红梅,祁玉曙,等.高原地区慢性肺心病心力衰竭患者血浆炎症因子、内皮素的变化及意义[J].医学研究杂志,2010,39(3):86-88.
[3] Gissi-HF Investigators,Tavazzi L,Maggioni AP,et al.Effect of rosuvastatin in patients with chronic heart failure(the GISSI-HF trial):a randomised,double-blind,placebo-controlled trial[J].Lancet,2008,372(9645):1231-1239.
[4] Neuhold S,Huelsmann M,Strunk G,et al.Comparison of copeptin,B-type natriuretic peptide,and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure:prediction of death at different stages of the disease[J].J Am Coll Cardiol,2008,52(4):266-272.
[5] Lainscak M,von Haehling S,Anker SD.Natriuretic peptides and other biomarkers in chronic heart failure:from BNP,NT-proBNP,and MR-proANP to routine biochemical markers[J].Int J Cardiol,2009,132(3):303-311.
[6] Adlbrecht C,Hülsmann M,Strunk G,et al.Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients[J].Eur J Heart Fail,2009,11(4):361-366.
[7] 黄鹤飞,赵冰冰,刘春霞,等.高压氧对慢性心力衰竭患者血浆内皮素-1的影响[J].实用医学杂志,2009,25(12):2013-2014.
[8] 上官文锋,李广平,周长钰,等.冠心病慢性左心衰竭患者肺动脉压、血清BNP和ET-1变化及临床意义[J].山东医药,2011,51(5):43-44.